Category: 86-51-1

Saglik, Begum Nurpelin published the artcileDesign, synthesis, and structure-activity relationships of thiazole analogs as anticholinesterase agents for Alzheimer’s disease, Recommanded Product: 2,3-Dimethoxybenzaldehyde, the main research area is thiazolylhydrazone preparation ADME mol docking anticholinesterase inhibitor Alzheimer disease; ADME parameters; Alzheimer’s disease; anticholinesterase enzyme activity; molecular docking; thiazole.

In this study, new thiazolylhydrazone derivatives I (R1 = H, OH, OMe; R2 = H, OH, OMe; R3 = H, OH, OMe; R4 = H, OMe; R2R3 = -OCH2O-) were designed and synthesized based on the cholinergic hypothesis. The ADME (absorption, distribution, metabolism, elimination) parameters of the synthesized compounds I were predicted by using QikProp 4.8 software. It was concluded that all compounds I presented satisfactory drug-like characteristics. Furthermore, their inhibitory activities against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in vitro were also tested by modified the Ellman spectrophotometric method. According to the results, all compounds I showed a weak inhibitory effect on BChE. On the other hand, most of the compounds I [R1 = R3 = R4 = H, R2 = OH (II); R1 = R2 = R4 = H, R3 = OH (III); R2 = R3 = R4 = H, R1 = OMe; R1 = R3 = R4 = H, R2 = OMe (IV); R1 = R4 = H, R2 = R3 = OMe (V); R1 = R4 = H, R2 = OH, R3 = OMe (VI); R1 = OH, R2 = R3 = H, R4 = OMe] had a certain AChE inhibitory activity, and the IC50 values of them were calculated as 0.063 ± 0.003, 0.056 ± 0.002, 0.147 ± 0.006, 0.040 ± 0.001, 0.031 ± 0.001, 0.028 ± 0.001, and 0.138 ± 0.005μM, resp. Among these derivatives, compound VI was found to be the most active agent in the series with an IC50 value of 0.028 ± 0.001μM, which indicated an inhibition profile at a similar rate as the reference drug, donepezil. The potential binding modes of compounds II, III, IV, V, and VI with AChE were investigated and compared with each other by the mol. docking studies. The results showed that these compounds were strongly bound up with the AChE enzyme active site with the optimal conformations.

Molecules published new progress about Absorption. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Recommanded Product: 2,3-Dimethoxybenzaldehyde.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Bassal, Ravit published the artcileRisk Factors for Multiple Infections with Salmonella, Shigella, and Campylobacter in Single Individuals Identified in Israel between 1999 and 2020: A Case-Case Control Study., Quality Control of 86-51-1, the main research area is .

BACKGROUND: Salmonella, Shigella, and Campylobacter are highly prevalent among children. Reports on risk factors of patients infected with all three pathogens, not simultaneously, are scarce. OBJECTIVES: To identify risk factors for multiple infection with Salmonella, Shigella, and Campylobacter in the same child. METHODS: Using the Israel Sentinel Laboratory-Based Surveillance Network, we conducted a retrospective observational case-case-control study among children aged 0-9 years. A case was defined as a child infected with Salmonella, Shigella, and Campylobacter at different occasions between January 1999 and December 2020. A control was defined as a child infected with a single pathogen once, during the same period. Logistic regression models were applied to determine the association between multiple infections and demographic characteristics. RESULTS: We identified 109 cases (0.1%) infected with Salmonella, Shigella, and Campylobacter, and 86,511 controls (99.9%) infected with only one bacteria type. In a multivariable analysis, we showed that being Jewish (odds ratio [OR] 2.4, 95% confidence interval [95%CI] 1.3-4.4), having residency in Jerusalem (OR 3.2, 95%CI 1.3-7.7), or in the southern district (OR 3.7, 95%CI 1.5-8.8) were independent risk factors for multiple infection. CONCLUSIONS: Although very rare, non-simultaneous infection with multiple bacteria does occur in Israel. National and local authorities should promote programs to encourage proper hygiene practices, which are culture-adjusted.

The Israel Medical Association journal : IMAJ published new progress in MEDLINE about 86-51-1, 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Quality Control of 86-51-1.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Yuan, Rui published the artcileSynthesis of 1,7-bis (N-substituted-aminomethyl)-2,8-dihydroxy-Troger’s bases and their application in Aldol-Ullmann reaction, Quality Control of 86-51-1, the main research area is aminomethyl dihydroxy Troger base preparation anti tumor human; hydroxylcoumarin electrophile Aldol Ullmann.

1,7-Bis (N-substituted-aminomethyl)-2,8-dihydroxy-Troger’s bases I (R = CH3, n-C4H9, C6H11, etc.) were synthesized and used as efficient organocatalyst for the Aldol reaction of 4-hydroxylcoumarin and 2-benzylidenemalononitrile (or Me (ethyl)-2-cyano-3-phenylacrylate) to afford 2-amino-4-aryl-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitriles II (R1 = H, p-F, p-OCH3, etc.; R2 = CN, COOMe, COOEt). Subsequently, they were used as the efficient ligand to promote the Pd-catalyzed Aldol-Ullmann reaction to give III (R = 4-OH, 2-OCH3, 4-F, etc.) and IV (R = 5-CH3, 5-OCH3, 5-Cl, etc.), resp. The anti-cancer activity on human three pos. breast cancer cells (MCF-7), human three neg. breast cancer cells (MDA-MB-231), human hepatoma cells (HepG2), human hepatoma cells (MHCC-97H) and cytotoxicity on human hepatocyte cells (LO2) of catalyst I and all products in vitro were evaluated. I (R = CH3) had selective inhibition (inhibition rate>30%) on MCF-7 cells while I (R = 1-phenylmethyl) and I (R = pyridin-2-methyl) had selective inhibition on MDA-MB-231 cells. II (R1 = 3,4,5-(OCH3)3; R2 = CN) had strong inhibitory effects on three kinds of cancer cells except MDA-MB-231 while II (R1 = p-Br; R2 = CN), II (R1 = 2,4-Cl2; R2 = CN), II (R1 = o-F; R2 = CN) and II (R1 = o-Br; R2 = CN) had strong inhibitory effects on four kinds of cancer cells. However, all the compounds showed cytotoxicity to normal LO2 cells which prompts the necessary of structure modification to reduce the toxicity.

Youji Huaxue published new progress about Aldol addition. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Quality Control of 86-51-1.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Yang, Heng published the artcileDBU-Promoted Intramolecular Crossed Aldol Reaction: A Facile Access to Indane-Fused Pyrrolidine, Application In Synthesis of 86-51-1, the main research area is DBU catalyst intramol cross aldol addition; indane fused pyrrolidine preparation.

A new strategy for the facile synthesis of indane-fused pyrrolidines through DBU-promoted intramol. crossed aldol reaction has been developed. The efficiency, compatibility and practicality of this method were demonstrated by a broad substrate scope, mild reaction conditions and gram-scale synthesis. The further derivatizations of the synthesized diastereoisomers I and II were performed for arylation, alkenylation, amination and etherification, showing high diastereoselectivities. Deuterium labeling experiment suggests a possible carbocation process which leads to the high diastereoselectivity during the transformations of I and II. Based on this strategy, the 5-HT2C agonist III and the antihypertensive agent IV were successfully synthesized through a three-step synthetic pathway. This new strategy potentially enables a wide exploration of these indane-fused derivatives applied for pharmaceuticals and related fields.

European Journal of Organic Chemistry published new progress about Aldol addition. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Application In Synthesis of 86-51-1.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Tripathi, Avanish published the artcileDesign and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer’s disease, SDS of cas: 86-51-1, the main research area is oxadiazole preparation Alzheimer disease docking antioxidant pharmacokinetic cholinesterase inhibitor; Acetylcholinesterase (AChE); Alzheimer’s disease; Aβ aggregation; Molecular hybridization; Multi-functional agents; β-Secretase-1 (BACE-1).

The diverse nature of Alzheimer’s disease (AD) has prompted researchers to develop multi-functional agents. Synthesized mol. hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles I (R = H, 3-Me, 2,4-dihydroxy, 3,4,5-trimethoxy, etc.) were designed. Biol. activities of synthesized compounds suggested significant and balanced inhibitory potential against target enzymes. In particular, compound I (R = 2,4-difluoro (A)) containing 2,4-difluoro substitution at terminal Ph ring considered as most potential lead with inhibition of acetylcholinesterase (hAChE, IC50 = 0.054 μM), butyrylcholinesterase (hBChE, IC50 = 0.787 μM) and beta-secretase-1 (hBACE-1, IC50 = 0.098 μM). The enzyme kinetics study of (A) against hAChE suggested a mixed type of inhibition (Ki = 0.030 μM). Also, I (R = 4-bromo) and (A) showed significant displacement of propidium iodide from the peripheral anionic site (PAS) of hAChE, excellent blood-brain barrier (BBB) permeability in parallel artificial membrane permeation assay (PAMPA), and neuroprotective ability against SH-SY5Y neuroblastoma cell lines. Further, (A) also exhibited anti-Aβ aggregation activity in self- and AChE-induced thioflavin T assay, which was ascertained by morphol. characterization by at. force microscopy (AFM). Moreover, in vivo behavioral studies signified learning and memory improvement by compound (A) in scopolamine- and Aβ-induced cognitive dysfunctions performed on Y-maze and Morris water maze. The ex vivo studies suggested decreased AChE activity and antioxidant potential of compound (A), with good oral absorption characteristics ascertained by pharmacokinetic studies.

European Journal of Medicinal Chemistry published new progress about Acute toxicity. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, SDS of cas: 86-51-1.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Sharma, Piyoosh published the artcileDesign and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer’s disease, Application In Synthesis of 86-51-1, the main research area is phenylmethylidene benzyl piperidinamine preparation docking acetylcholinesterase secretase inhibition SAR; dibenzylpiperidinamine preparation docking acetylcholinesterase secretase inhibition SAR; Acetylcholinesterase (AChE); Alzheimer’s disease; Aβ aggregation; Multitarget-directed ligands; Structure-based drug design; β-Secretase-1 (BACE-1).

A series of N-benzylpiperidine analogs I and II [R = H, 4-F, 2,3-(MeO)2, etc.] were designed and synthesized as multi-functional inhibitors of acetylcholinesterase (AChE) and β-secretase-1 (BACE-1) with moderate to excellent inhibitory activities. Among the tested inhibitors, I and II [R = 4-O2N, 4-F3C] presented the most significant and balanced inhibition against both the targets. Compounds I [R = 4-O2N, 4-F3C] exhibited high brain permeability in the PAMPA-BBB assay, significant displacement of propidium iodide from the peripheral anionic site (PAS) of AChE and were devoid of neurotoxicity towards SH-SY5Y neuroblastoma cell lines up to the maximum tested concentration of 80 μM. Meanwhile, both these compounds inhibited self- and AChE-induced Aβ aggregation in thioflavin T assay, which was also re-affirmed by morphol. characterization of Aβ aggregates using at. force microscopy (AFM). Moreover, I [R = 4-O2N, 4-F3C] ameliorated the scopolamine-induced cognitive impairment in elevated plus and Y-maze experiments Ex-vivo and biochem. anal. established the brain AChE inhibitory potential and antioxidant properties of these compounds Further, improvement in Aβ1-42-induced cognitive impairment was also observed by compound I [R = 4-F3C] in the Morris water maze experiment with significant oral absorption characteristics ascertained by the pharmacokinetic studies.

European Journal of Medicinal Chemistry published new progress about Acute toxicity. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Application In Synthesis of 86-51-1.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Mitkov, Javor published the artcileSynthesis, in silico prediction of sites of metabolism and in-vitro hepatotoxicity evaluation of new series N′-substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio) propanehydrazides, Recommanded Product: 2,3-Dimethoxybenzaldehyde, the main research area is trimethyl xanthinylthio propanehydrazide metabolism invitro hepatotoxicity evaluation.

New series of 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazide derivatives were designed and synthesized. The targed compounds were obtained in yields of 54 to 100% and their structures were elucidated by FTIR,1H NMR,13C NMR, MS and microanalyses. The tested compounds were subjected to in silico prediction of sites of metabolism (SOMs). The predictions show thatthe main metabolic changes will be primarily related to oxidation of the sulfur atom in the side chain, carried out under the action of CYP2C19, as well as O-demethylation of compounds containing methoxy groups. The N-demethylation of the xanthine fragment was determined to be regulated by CYP1A2, CYP2C9, CYP2D6 and CYP3A4. Theperformed in vitro studies confirmed for two of the tested compounds to be low hepatotoxic, due to the presented prooxidant effects at subcellular level (isolated rat liver microsomes). These results highlight these mols. as promising hydrazide-hydrazone structures for the design of compounds with low hepatotoxicity.

Pharmacia (Sofia, Bulgaria) published new progress about Bioavailability. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Recommanded Product: 2,3-Dimethoxybenzaldehyde.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Ilyina, Irina V. published the artcileInfluenza antiviral activity of F- and OH-containing isopulegol-derived octahydro-2H-chromenes, COA of Formula: C9H10O3, the main research area is fluoro hydroxy octahydrochromene preparation isopulegol Prins influenza treatment; Antiviral; Chromene; Fluorine; Influenza; Monoterpene.

The authors synthesized fluoro- and hydroxy-containing octahydro-2H-chromenes by the Prins reaction starting from a monoterpenoid (-)-isopulegol and a wide range of aromatic aldehydes in the presence of the BF3•Et2O/H2O system acting as both an acid catalyst and a fluorine source. Activity of the produced compounds against the influenza A/Puerto Rico/8/34 (H1N1) virus was studied. The highest activity was demonstrated by fluoro- and hydroxy-containing derivatives of 2,4,6-trimethoxybenzaldehyde. The most pronounced virus-inhibiting effect of compounds 10i and 11i was observed at an early stage of infection. These compounds were supposed to be capable of binding to viral hemagglutinin, which is an agreement with data on the effect of compounds 10i and 11i on the viral fusogenic activity as well as by mol. docking studies.

Bioorganic & Medicinal Chemistry Letters published new progress about Antiviral agents. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, COA of Formula: C9H10O3.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Zima, Vaclav published the artcileUnraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors, Recommanded Product: 2,3-Dimethoxybenzaldehyde, the main research area is flavonoid analog structure preparation influenza endonuclease inhibitor; Influenza; Neuraminidase; PA(N) endonuclease Inhibitors; Polyphenols; RNA polymerase.

The biol. effects of flavonoids on mammal cells are diverse, ranging from scavenging free radicals and anti-cancer activity to anti-influenza activity. Despite appreciable effort to understand the anti-influenza activity of flavonoids, there is no clear consensus about their precise mode-of-action at a cellular level. Here, we report the development and validation of a screening assay based on AlphaScreen technol. and illustrate its application for determination of the inhibitory potency of a large set of polyols against PA N-terminal domain (PA-Nter) of influenza RNA-dependent RNA polymerase featuring endonuclease activity. The most potent inhibitors we identified were luteolin with an IC50 of 72 ± 2 nM and its 8-C-glucoside orientin with an IC50 of 43 ± 2 nM. Submicromolar inhibitors were also evaluated by an in vitro endonuclease activity assay using single-stranded DNA, and the results were in full agreement with data from the competitive AlphaScreen assay. Using X-ray crystallog., we analyzed structures of the PA-Nter in complex with luteolin at 2.0 Å resolution and quambalarine B at 2.5 Å resolution, which clearly revealed the binding pose of these polyols coordinated to two manganese ions in the endonuclease active site. Using two distinct assays along with the structural work, we have presumably identified and characterized the mol. mode-of-action of flavonoids in influenza-infected cells.

European Journal of Medicinal Chemistry published new progress about Antiviral agents. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Recommanded Product: 2,3-Dimethoxybenzaldehyde.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Subtelna, Ivanna published the artcile5-Arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones with selective inhibitory activity against some leukemia cell lines, COA of Formula: C9H10O3, the main research area is anticancer antileukemic leukemia 2imino4thiazolidinone; 2-imino-4-thiazolidinones; anticancer activity; antileukemic activity; leukemia cell lines.

The data on the pharmacol. of 4-thiazolidinones showed that 5-ene-2-(imino)amino-4-thiazolidinones are likely to comprise one of the most promising groups of compounds possessing anticancer properties. A series of 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones was designed, synthesized, and studied against 10 leukemia cell lines, including the HL-60, Jurkat, K-562, Dami, KBM-7, and some Ba/F3 cell lines. The structure-activity relationship anal. shows that almost all tested 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones were characterized by IC50 values lower or comparable to that of the control drug chlorambucil. Among the tested compounds, (5Z)-5-(2-methoxybenzylidene)- (12), (5Z)-(2-ethoxybenzylidene)- (21), (5Z)-5-(2-benzyloxybenzylidene)- (25), and (5Z)-5-(2-allyloxybenzylidene)-2-(4-hydroxyphenylamino)thiazol-4(5H)-ones (28) possessed the highest antileukemic activity at submicromolar concentrations (IC50 = 0.10-0.95μM).

Archiv der Pharmazie (Weinheim, Germany) published new progress about Antitumor agents. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, COA of Formula: C9H10O3.

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem